SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (19111)2/25/1999 8:09:00 PM
From: DaiS  Respond to of 23519
 
Vlad,

What I would like to know about the gene therapy work is whether the K channel technology to facilitate smooth muscle relaxation could be used for therapy of other diseases. My medical knowledge is not good enough to assess this. If there are prospects, we might hope that Vivus is in on this.

DaiS



To: VLAD who wrote (19111)2/25/1999 8:13:00 PM
From: DaiS  Read Replies (1) | Respond to of 23519
 
Vlad,

I think you already admitted that at well 15 or so you might make a dignified exit?

Can any of us bear to stick around after all this pain? If by some miracle Vivus ever makes it big to the $80 stock that Nina told you it should be, probably will be new group of investors posting here.

DaiS


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News